The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...
In keeping with our new Diabetes Canada Guidelines that all people with type 1 diabetes should use an AID System, the arrival of Omnipod 5 will be life changing for many people living with ...
Zacks Investment Research on MSN3d
Insulet Gains 62.9% in a Year: What's Driving the Stock?Insulet Corporation PODD has witnessed strong momentum in the past year. Shares of the company have risen 62.9% compared with 9.9% growth of the industry during the same time frame. The S&P 500 ...
Insulet Corporation (NASDAQ: PODD) ("Insulet" or the "Company"), the global leader in tubeless insulin pump technology with ...
“When she got the Omnipod 5, it changed everything.” Unlike traditional insulin pumps that use tubes, the Omnipod 5 adheres ...
Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced its intention ...
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Australia, launching soon in Belgium, Canada, and Switzerland. Omnipod 5 is now commercially available in Australia ...
"Canadians living with type 1 diabetes have been anxiously awaiting the arrival of Omnipod 5, the only tubeless commercial AID System. In keeping with our new Diabetes Canada Guidelines that all ...
Insulet (PODD) announced its revolutionary Omnipod 5 Automated Insulin Delivery System is now available in Australia and will soon be offered in three additional countries, helping transform the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback